News - Neurological, Reproductive

Filter

Current filters:

NeurologicalReproductive

Popular Filters

EMA Pharmacovigilance committee calls for Tredaptive suspension; contraceptives update

13-01-2013

At meetings held last week, the European Medicines Agency's Pharmacovigilance Risk Assessment Committee…

Cardio-vascularEuropeMerck & CoNeurologicalPharmaceuticalRegulationReproductivetetrazepamTredaptive

Pfizer's Lyrica positive in two post-marketing studies

23-07-2012

Top-line results for global drugs behemoth Pfizer's already marketed diabetic nerve pain and post-herpetic…

LyricaNeurologicalPfizerPharmaceuticalReproductiveResearch

Warner Chilcott sues Watson over Lo Loestrin; Actavis debuts generic Requip

20-05-2012

Ireland-headquartered Warner Chilcott (Nasdaq: WCRX) has filed suit against USA-based Watson Pharmaceuticals…

ActavisGenericsGlaxoSmithKlineLegalLo LoestrinMarkets & MarketingNeurologicalNorth AmericaPatentsRegulationReproductiveRequip XLWarner ChilcottWatson Pharmaceuticals

Mylan settles with Novartis over Vivelle-Dot; Impax files for generic Fentora

21-11-2011

US generics drugmaker Mylan (Nasdaq: MYL) says it has settled a patent litigation law suit with the US…

CephalonCIMA LabsFentoraGenericsImpax LaboratoriesMylan LaboratoriesNeurologicalNorth AmericaNovartisPatentsRegulationReproductiveVivelle-Dot

Watson challenges Exelon patent; wins Seasonique appeal; launches generic Kadian

13-11-2011

There was an active day for US generics drugmaker Watson Pharmaceuticals (NYSE: WPI), first, confirming…

ActavisDuramed PharmaceuticalsExelonGenericsKadianMarkets & MarketingNeurologicalNorth AmericaPatentsReproductiveSeasoniqueWatson Pharmaceuticals

Changing the mood of Brazilian antidepressant market; fake Levitra

24-08-2011

The Vice President of Brazil’s Superior Court of Justice (STJ), Minister Felix Fischer, has restored…

BayerGenericsLevitraLexaproLundbeckNeurologicalPharmaceuticalRegulationReproductiveSouth America

Back to top